Brand Name(s): Zocor, Vytorin

CAS nº: 79902-63-9

(sim' va stat in)


About Simvastatin

This new site is dedicated exclusively to simvastatin.

It offers you the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about simvastatin, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total simvastatin experience! 

Why is this medication prescribed?

Simvastatin is a hypolipidemic drug belonging to the class of pharmaceuticals called "statins". Simvastatin is used to control hypercholesterolemia (elevated cholesterol levels) and to prevent cardiovascular disease. Simvastatin is a synthetic derivate of a fermentation product of Aspergillus terreus.

Some of the brand names of simvastatin include Zocor® and Zocor Heart Pro®, marketed by the pharmaceutical company Merck & Co., as well as Denan® (Germany), Liponorm®, Sinvacor®, Sivastin® (Italy), Lipovas® (Japan), Lodales® (France), Zocord® (Austria and Sweden), and Simvahexal® and Lipex® (Australia) amongst others.

The U.S. patent applied to Zocor® recently expired in June 23, 2006. Israel-based Teva Pharmaceuticals & India-based Ranbaxy have been given approval to manufacture and sell simvastatin from this date.

See more Product Info

Latest News

Congressmen Examine Web Postings in Vytorin Probe

Anonymous messages posted on a Web site raise questions about the handling of data on a Merck & Co...

[more]

FDA Rejects OTC Mevacor (Pharm Aid)

In the blog, the author writes about the not-approvable letter for Merck’s OTC version of the...

[more]

NY Subpoenas Merck, Schering-Plough over Vytorin

New York Attorney General Andrew Cuomo has subpoenaed Merck & Co and Schering-Plough Corp for...

[more]

Vytorin Prescriptions Down 23% Since Controversial Trial

Prescriptions for Merck & Co.'s (MRK) and Schering- Plough Corp.'s (SGP) embattled cholesterol drug...

[more]

Cholesterol-lowering Drugs May be Useful in Prevention of Cancer

A recent study published in the Journal of the National Cancer Institute reports that...

[more]

Advertisement
Join Extrapounds.com and enjoy healthy weight loss!

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.